DOR BioPharma's Cash Flow from Operations Deteriorates 18.6%
Stock Quote:(N/A:DORB)
08/21/2009
0.00
N/A
N/A
0
DOR BioPharma's Cash Flow from Operations Deteriorates 18.6%
Last
Price Change
% Chg
Volume
New York, NY, August 21, 2009-CFFO-NEWS reports that negative Cash Flow from Operations for DOR BioPharma, Inc. (OTC:DORB) for its twelve months ended June 30, 2009 was $(4,248,424), a 18.6% deteriora ... read full story
The indices continue to rally at midday, and stocks have seen their best one-day performance since July 2009 during this session after an easing of fears regarding sovereign debt issues in Europe. An earlier report today had indictated that the Euro ... read full story
N/A 
